Healthcare AI is moving from pilots to enterprise-wide adoption and accountability.
Healthcare AI is moving from pilots to enterprise-wide adoption and accountability.
AI success depends on workflow fit, governance maturity and scalable infrastructure.
ROI optimism is strong, but measuring financial impact remains a challenge.
Healthcare organizations have moved past artificial intelligence experimentation. In RSM’s 2026 AI survey of middle market organizations, 84% of healthcare respondents whose organization uses AI reported that AI is already partially or fully integrated across operations and processes. To bring those numbers to life, RSM conducted two focus group conversations* with healthcare executives to gain further perspectives on AI uses, challenges and more. What follows are the key themes and insights that emerged from the survey and focus groups.
Of the 70 health care respondents who participated, 40% reported full AI integration across core processes, and another 44% reported partial integration. Inside organizations, the picture is more layered. Leaders described AI as often leveraged through embedded vendor tools rather than implemented as a deliberate strategy, with maturity varying widely across functions.
Administrative use cases are scaling far faster than clinical ones. As one focus group participant put it: “From an administrative perspective, very high. From a clinical perspective, probably not 84%.” Ambient documentation has emerged as the clearest near-term clinical bright spot, described in the same discussion as “growing like wildfire with our provider community.”
Momentum often slows not at the pilot stage, but as healthcare organizations try to scale AI. According to the survey the top inhibitors are:
Focus group participants reinforced that scaling stress tests infrastructure, processes and readiness in ways pilots never do. Leaders pointed less to the tools themselves and more to gaps in the surrounding workflows.
“Every good AI fails if it doesn’t fit the workflow,” said one participant. “You really have to take a look at the workflow first.”
AI also exposes upstream weaknesses, with IT effort shifting toward fixing the data quality, lineage and access issues that AI surfaces.
The survey shows AI strategy ownership is distributed across the CEO (27%), IT (26%) and the senior AI roles such as the chief AI officer and the head of AI or AI center of excellence (24%). And 94% of healthcare respondents reported having governance controls in place, yet 13% said controls are applied only after issues arise, and 9% said they are applied inconsistently.
Focus group participants acknowledged adoption frequently outpaces oversight. “People start using these tools a little bit faster than sometimes we would like until you have governance,” one participant said.
Another captured the challenge bluntly: “We’re trying to be compliant without knowing what compliance is.”
Governance that builds confidence is designed early on, not retrofitted.
Healthcare organizations reported they evaluate AI return on investment most often through:
Customer experience and satisfaction
Employee experience and satisfaction
Process efficiency
Compliance improvement
Optimism is high: Among those who measure AI ROI (99%) a large majority said AI has met or exceeded their expectations for ROI (90%). That optimism comes with caveats. Focus group members described persistent difficulty translating soft gains into board-level outcomes.
“Everybody comes out, says you’re going to become more efficient,” one participant noted. “But when I say ‘Let’s quantify that,’ it’s crickets.”
AI’s most defensible value today is its ability to increase financial and operational efficiency and address clinical and capacity needs, though real return on investment dollars remains harder to quantify.
When asked what would signal AI success in the coming year, healthcare survey respondents most commonly cited:
Improved employee efficiency
Better decision making
Improved customer experience
Clear AI governance
Focus group participants framed success differently, moving away from one-off tools and toward reusable platforms, fewer experiments and more confidence in governance.
“A year from now, what I don’t want to be is talking about AI,” one healthcare executive said. “What I want to talk about is solutions—what problems has it solved?”
AI usage decisions increasingly involve prioritization, not just enthusiasm. The survey found that 86% of healthcare respondents expect their workforce size or composition to look fundamentally different in two to three years because of AI, and 79% expect AI spend to increase next fiscal year.
Among organizations expecting an increase AI spend, they most commonly expect reductions in:
Business intelligence or analytics initiatives
Cybersecurity investments
Legacy application modernization
Robotic process automation or other broader automation
Most organizations are pursuing or plan to pursue a hybrid AI model—building additional capabilities in-house (89%), buying from external providers (86%) and engaging external advisors (84%)—to balance speed with capability.
Healthcare AI is shifting from experimentation toward accountability, confidence and sustainable impact. The leaders who shared their perspectives across these focus groups described the next phase as quieter and more disciplined—fewer tools, clearer outcomes and governance that enables rather than restrains.
*Focus groups: In May 2026, RSM conducted two one-hour virtual focus groups with nine senior-level IT and technology professionals recruited through the College of Healthcare Information Management Executives (CHIME) and the Healthcare Information and Management Systems Society (HIMSS). All participants were based in the United States, with five holding a membership in CHIME and four holding a membership in HIMSS. Results from the focus groups are qualitative in nature and cannot be projected to the full population.
Discover how organizations are approaching AI adoption, overcoming barriers and preparing to scale enterprise value.